You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Strategies of Sequential Therapies in Unresectable, Metastatic Colorectal Cancer Treated with Palliative Intent

ID: 2-5 jan 2014
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
T. Asmis, S. Berry, R. Cosby, K. Chan, N. Coburn, M. Rother , Gastrointestinal Disease Site Group

Patient Population

Adult patients (≥18 years old) with unresectable metastatic colorectal cancer.

Intended Guideline Users

Clinicians and healthcare providers involved in the management of patients with unresectable, metastatic colorectal cancer treated with palliative intent.

Research Question(s)

What is the impact of different strategies of sequential and combination chemotherapy on efficacy (including overall survival), toxicity and quality of life in unresectable metastatic colorectal cancer treated with palliative intent?

The cytotoxic agents covered in this guideline include initial fluoropyrimidine (5-FU or capecitabine) either alone or in combination, irinotecan and oxaliplatin.

pdf download Summary (PDF) (173.19 Ko)
pdf download Full Report (PDF) (581.78 Ko)